Securities Fraud Investigation Into GE HealthCare Technologies In
The Law Offices of Frank R. Cruz are continuing their securities fraud investigation into GE HealthCare Technologies Inc. (NASDAQ: GEHC) following a significant stock price drop. This investigation concerns potential violations of federal securities laws after the company reported lower-than-expected adjusted earnings per share for Q1 2026 and cut its full-year guidance, citing recalls and supplier issues. Shareholders who lost money are urged to contact the firm to inquire about pursuing a claim.
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
The Law Offices of Howard G. Smith are investigating GE HealthCare Technologies Inc. (GEHC) for potential federal securities law violations after the company reported lower-than-expected Q1 2026 financial results and cut its full-year EPS guidance. This news led to a 13.2% stock price drop on April 29, 2026, causing losses for shareholders. Investors who lost money are encouraged to contact the law firm to discuss their legal rights.
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
The Law Offices of Howard G. Smith are investigating GE HealthCare Technologies Inc. (GEHC) for potential federal securities law violations following a significant stock drop. This investigation comes after GE HealthCare reported adjusted earnings per share of $0.99 for Q1 2026 and cut its full-year EPS guidance due to a product recall and declines in PCS performance, leading to a 13.2% share price decrease. Shareholders who incurred losses are encouraged to contact the law firm to discuss their legal rights.
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz is continuing its investigation into GE HealthCare Technologies Inc. (GEHC) regarding possible violations of federal securities laws. This stems from GE HealthCare's Q1 2026 financial results, where the company reported adjusted earnings per share of $0.99 and cut its full-year 2026 adjusted EPS guidance due to a recall associated with a PDX supplier and declining PACS performance. Following this news, GE HealthCare's share price dropped by $10.01, or 13.2%, to close at $65.99 on April 26, 2026.
Intuitive readies 100 updates and improvements for da Vinci 5
Intuitive is preparing to roll out over 100 updates and user experience improvements for its da Vinci 5 surgical robot, starting in June in the U.S. These enhancements aim to boost communication between remote and on-site physicians, simplify access, and improve educational opportunities. The updates also include increasing the number of uses for several force-feedback instruments, which could reduce per-procedure costs amidst growing competition in the robotic surgery market.
Koninklijke Philips N.V. stock (NL0000009538): Investors react to legal settlement push and portfolio shift
Koninklijke Philips N.V. is navigating a costly US sleep apnea settlement and shifting its focus to medical technology. The company's recent quarterly figures and updated legal provisions for the Respironics recall are influencing investor perception. Philips aims to rebuild profitability in its core medical equipment businesses amidst these financial and legal challenges.
UBS Upgrades GE HealthCare Technologies(GEHC.US) to Hold Rating, Cuts Target Price to $69
UBS analyst Graham Doyle has upgraded GE HealthCare Technologies (GEHC.US) from a previous rating to "Hold" but simultaneously lowered the target price from $77 to $69. This adjustment reflects a moderated outlook for the company by the analyst. According to TipRanks data, this analyst has a 46.2% success rate and an average return of -2.8% over the past year.
J&J Advances Creation of Global Intelligent OR Network with Abu Dhabi
Johnson & Johnson has partnered with the Department of Health – Abu Dhabi to launch a global program for developing an open surgical intelligence network. This initiative establishes Abu Dhabi as the initial hub for accelerating AI innovation in surgery, integrating J&J's Polyphonic™ digital ecosystem with local health systems and technology partners like AWS and NVIDIA. The program aims to connect operating rooms across Abu Dhabi to a surgical intelligence system, improving patient outcomes through structured data and AI development.
Neogen Corp stock (US6404911066): share jumps after strong quarterly update and integration progress
Neogen Corp's stock experienced a jump following a strong quarterly report that highlighted solid growth in food safety testing and significant progress in integrating the acquired 3M food safety business. The company's focus on food safety solutions and animal health products, alongside strategic acquisitions and ongoing innovation, are key drivers. Investors are closely watching the company's ability to convert revenue growth into sustained margin expansion as it continues to integrate the 3M assets and optimize its global footprint.
GE HealthCare Technologies Inc. (GEHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into GE HealthCare Technologies Inc. (GEHC) following its Q1 2026 financial results. The company reported adjusted EPS of $0.99, missing consensus estimates, and cut its full-year EPS guidance due to a PDx supplier issue. This news led to a significant drop in GE HealthCare's stock price, and the firm is encouraging investors to contact them for more information regarding potential claims.
UBS Upgrades GE Healthcare Technologies to Neutral From Sell, Adjusts Price Target to $69 From $75
UBS has upgraded GE Healthcare Technologies' stock rating from Sell to Neutral, while also adjusting its price target from $75 down to $69. This change reflects a revised outlook on the company's financial performance or market position.
UBS Upgrades GE Healthcare Technologies to Neutral From Sell, Adjusts Price Target to $69 From $75
UBS has upgraded GE Healthcare Technologies (GEHC) from a "Sell" rating to "Neutral," while also adjusting its price target. The new price target for GE HealthCare Technologies is set at $69, a decrease from the previous target of $75. This change reflects a revised outlook from the financial services firm regarding the company's stock performance.
Pixie Dust Technologies Raises Approximately ¥3.3 Billion in Series D Funding
Pixie Dust Technologies, a company specializing in healthcare and spatial acoustics using wave control technology, has raised approximately ¥3.3 billion in Series D funding. The capital, secured through third-party allotment, venture debt, and a syndicated loan, will be used to expand sales channels, promote R&D, develop new products, and enter global markets. Incubate Fund and Itochu Technology Ventures participated in the funding round.
GE HealthCare Offering Free Healthcare AI Training
GE HealthCare is providing over 20 hours of free healthcare AI training through its HelloAI program, along with access to expert webinars. This initiative aims to improve AI fluency among healthcare professionals, as AI adoption among physicians has more than doubled, but training has not kept pace. The program focuses on enabling confident and responsible application of AI to enhance productivity, decision-making, and outcomes.
Barclays (DJP) sells $2.63M AutoCallable Contingent Coupon Notes, 9.70% p.a.
Barclays Bank PLC is offering $2.63 million in AutoCallable Contingent Coupon Notes, set to mature on May 23, 2029, with a contingent annual coupon rate of 9.70%. These notes are linked to the performance of four equity securities: BDX, GEHC, ZBH, and DHR, and investors' principal repayment at maturity is subject to the performance of the least performing reference asset. The offering includes potential risks such as loss of principal, dependence on Barclays' creditworthiness and the U.K. Bail-in Power, and limited upside potential compared to direct equity ownership.
AI scribe note quality under question as adoption grows
New research indicates that while ambient AI scribes can save time for clinicians, they also raise concerns about the quality of clinical notes. A vendor-neutral study found AI-generated notes scored lower than human-written notes in areas such as thoroughness, organization, and clinical usefulness, especially in challenging environments like those with background noise or non-native English speakers. This suggests that AI scribes may exacerbate care disparities and necessitate careful review and robust governance to ensure safe and equitable deployment in healthcare.
GE HealthCare Technologies Inc. stock rises Wednesday, outperforms market
GE HealthCare Technologies Inc. (GEHC) saw its stock rise by 4.35% on Wednesday, closing at $64.26, outperforming the broader market. This marked the third consecutive day of gains for the company's stock, as the S&P 500 Index and the Dow Jones Industrial Average also experienced increases.
Intuitive Surgical stock (US46120E6023): da Vinci maker in focus after latest earnings and analyst u
Intuitive Surgical remains a key focus for investors following its recent quarterly earnings report and subsequent analyst comments. The company, known for its da Vinci robotic surgery systems, reported double-digit procedure growth and increased revenue, while also emphasizing ongoing investments in R&D and regulatory advancements. Investors are closely monitoring its procedure growth, system launches, and margins as it navigates a competitive medical technology market.
With Strong Cash Flow, GE HealthCare Technologies Stock Poised to Rise?
GE HealthCare Technologies (GEHC) presents a compelling investment opportunity due to its strong cash flow yield of 5.4%, robust operating margin of 12.6%, and a discounted valuation against its 2-year and 1-month highs. Despite facing low revenue growth, the company's fundamentals appear solid when compared to S&P medians. However, investors are cautioned to consider the inherent risks of single stock trades and market volatility, with alternatives and portfolio diversification strategies suggested by Trefis.
High Cash Flow Stocks with Weak Returns: Illinois Tool Works, Align Technology, GE HealthCare - News and Statistics
An analysis by StockStory highlights that strong cash flow does not always equate to strong investment returns, citing companies like Illinois Tool Works, Align Technology, and GE HealthCare as examples. These companies, despite generating substantial cash, face challenges such as sluggish revenue growth, declining operating margins, or difficulties in organic expansion. The article details specific financial and operational issues for each company, suggesting that other factors beyond cash flow heavily influence their market performance.
Stryker’s Amplitude Deal Extends Peripheral Vascular Reach And Investor Debate
Stryker (NYSE:SYK) has announced its acquisition of Amplitude Vascular Systems for up to $835 million, integrating next-generation hydraulic intravascular lithotripsy technology into its peripheral vascular portfolio. This strategic move aims to enhance Stryker's presence in treating peripheral arterial disease. The deal has generated investor interest, particularly given Stryker's recent mixed stock performance, highlighting a push towards business expansion and capital allocation decisions.
INVESTOR ALERT: Securities Class Action Filed Against Sportradar Group AG – Investors Encouraged to Contact Kirby McInerney LLP
Kirby McInerney LLP has filed a securities class action lawsuit against Sportradar Group AG (NASDAQ:SRAD) on behalf of investors who purchased securities between November 7, 2024, and April 21, 2026. The lawsuit alleges that Sportradar intentionally collaborated with black-market gambling operators, contrary to its claims of strict compliance and integrity, and that its compliance processes were not robust. This action follows reports from short sellers Muddy Waters Research and Callisto Research, which led to a significant drop in Sportradar's stock price after revelations about its links to illegal gambling markets and ongoing regulatory reviews.
GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.
Kirby McInerney LLP is investigating potential claims against GE HealthCare Technologies Inc. following a significant drop in its stock price. This decline occurred after GE HealthCare reported lower-than-expected adjusted earnings per share and cut its full-year 2026 guidance, attributing the miss to a resolved PDx supplier issue. The firm is encouraging investors who purchased GE HealthCare securities to contact them to discuss their legal rights regarding possible federal securities law violations.
Thermo Fisher Scientific expands global biobank leadership through strategic collaboration with PRECISE-SG100K Singapore to advance population-scale proteomics
Thermo Fisher Scientific is collaborating with Precision Health Research, Singapore (PRECISE) to support its PRECISE-SG100K study, a major population-scale biobank initiative. This partnership focuses on advancing population-scale proteomics to improve disease detection, prevention, and personalized care. The collaboration will integrate Thermo Fisher's Olink® Proximity Extension Assay platforms and Orbitrap Astral mass spectrometry system with Seer’s Proteograph® Product Suite to provide comprehensive proteomic analysis, enabling the translation of biological data into new disease mechanisms and biomarker insights.
FinancialContent - Bragar Eagel & Squire, P.C. Continues Investigating GE HealthCare Technologies Inc. on Behalf of GE HealthCare Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against GE HealthCare Technologies Inc. (NASDAQ: GEHC) on behalf of its stockholders. This investigation follows GE HealthCare's Q1 2026 financial results, where the company reported adjusted earnings per share below consensus and reduced full-year guidance, leading to a significant stock price drop. The law firm is encouraging investors who suffered losses to contact them to discuss their legal options.
Bragar Eagel & Squire, P.C. Continues Investigating GE HealthCare Technologies Inc. on Behalf of GE HealthCare Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a stockholder rights law firm, is investigating potential claims against GE HealthCare Technologies Inc. following the company's Q1 2026 financial results. The investigation centers on GE HealthCare missing consensus EPS estimates and lowering its full-year guidance, which led to a significant 13% drop in stock price. The firm is encouraging investors who suffered losses to contact them to discuss legal options.
Bronstein, Gewirtz & Grossman, LLC Encourages GE HealthCare Techn
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of GE HealthCare Technologies Inc. (NASDAQ: GEHC) shareholders. This investigation follows a recent report where GE HealthCare missed consensus earnings estimates and cut its full-year EPS guidance, largely due to a PDx supplier issue. The firm encourages affected shareholders to inquire about the securities investigation.
GE HealthCare (GEHC) grants 16,458 RSUs to AIS CEO Philip Rackliffe
GE HealthCare Technologies Inc. announced that Philip Rackliffe, CEO of AIS, received a grant of 16,458 restricted stock units (RSUs). These units will vest in two equal halves on May 15, 2028, and May 15, 2029, and entitle him to one share of common stock per unit upon settlement. Following this award, Rackliffe directly holds 43,187 shares of GE HealthCare common stock, with the grant serving as long-term equity-based compensation.
GE HealthCare (GEHC) exec withholds 5,535 shares for RSU taxes
GE HealthCare Technologies Inc. executive Jeannette Bankes, CEO of Patient Care Solutions, engaged in a routine share withholding to cover tax obligations. On May 15, 2026, 5,535 shares of common stock were withheld at $62.67 per share due to vesting restricted stock units. This transaction was a tax-withholding disposition, not an open-market sale, and Bankes now directly holds 38,357 GE HealthCare shares.
IDEXX Laboratories (Nasdaq:IDXX) - Stock Analysis
This report provides a comprehensive stock analysis of IDEXX Laboratories (IDXX), covering its market performance, financial health, future growth predictions, and recent news. Key highlights include its Q1 2026 revenue growth and increased full-year guidance, driven by strong diagnostics and new product integration like the SDMA kidney biomarker. The analysis also touches on analyst sentiment, insider transactions, and comparisons to competitors.
Argus Adjusts PT on GE Healthcare Technologies to $80 From $95, Maintains Buy Rating
Argus has adjusted its price target for GE Healthcare Technologies (GEHC) to $80, down from $95, while reiterating a "Buy" rating on the stock. This update reflects a revised valuation perspective by the firm. The article, however, does not provide further details on the rationale behind the price target modification.
Koninklijke Philips N.V. stock (NL0000009538): new SmartIQ imaging launch keeps focus on health-tech
Koninklijke Philips N.V. (NYSE: PHG) has launched its SmartIQ technology for coronary X-ray procedures, aiming to reduce radiation dose while maintaining image quality. Despite beating analyst expectations in its most recent quarter, the stock trades below its 200-day moving average, reflecting lingering investor skepticism due to past recall and supply-chain issues. The article highlights Philips' strategic shift to health-technology, its competitive position, and the risks and opportunities for US investors.
Bronstein, Gewirtz & Grossman, LLC Is Investigating GE HealthCare
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against GE HealthCare Technologies Inc. (NASDAQ: GEHC) on behalf of its investors. This investigation follows GE HealthCare's announcement of first-quarter 2026 financial results that missed consensus estimates and a cut to its full-year EPS guidance, primarily due to a PDx supplier issue. The news led to a significant drop in GE HealthCare's stock price.
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP has launched a securities fraud investigation into GE HealthCare Technologies Inc. (GEHC) after the company reported lower-than-expected Q1 2026 earnings and cut its full-year EPS guidance. The investigation focuses on potential violations of federal securities laws, prompted by a significant stock price drop following disclosures of a product recall and its impact on profit performance. Shareholders who experienced losses are encouraged to contact the firm to discuss potential claims.
FinancialContent - GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
The Law Offices of Howard G. Smith are investigating GE HealthCare Technologies Inc. (GEHC) for possible violations of federal securities laws after the company reported lower-than-expected adjusted EPS and cut its full-year guidance for 2026. This announcement followed a stock price decline of 13.2% after the company disclosed impacts from a product recall and supplier issues. Shareholders who suffered losses are encouraged to contact the law firm regarding potential securities fraud claims.
North Dakota State Investment Board Invests $6.93 Million in Intuitive Surgical, Inc. $ISRG
The North Dakota State Investment Board has acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG), purchasing 12,238 shares valued at approximately $6.93 million. This comes amidst other hedge funds adjusting their stakes in the medical equipment provider, and various analyst reports and positive sentiment regarding Intuitive Surgical's integration of AI in healthcare and the performance of its da Vinci 5 system.
BTIG Reiterates GE HealthCare Technologies (GEHC) Buy Recommendation
GE HealthCare Technologies (GEHC) received a reiterated Buy recommendation from BTIG. The financial firm maintained its positive outlook on the company following the announcement of its Q1 2024 earnings.
BTIG Reiterates GE HealthCare Technologies (GEHC) Buy Recommendation
BTIG has reiterated its Buy recommendation for GE HealthCare Technologies (GEHC). The company continues to show strong performance indicators, reinforcing the analyst's positive outlook. This reiteration suggests ongoing confidence in GEHC's market position and future growth prospects.
DNB Asset Management AS Has $13.40 Million Stake in Flutter Entertainment PLC $FLUT
DNB Asset Management AS significantly reduced its stake in Flutter Entertainment PLC by 79.7% in the fourth quarter, now holding 62,300 shares valued at approximately $13.4 million. Despite this reduction, Flutter reported stronger-than-expected quarterly earnings with EPS of $1.22 and revenue of $4.30 billion, alongside authorizing a $250 million share repurchase plan. Wall Street analysts maintain a "Moderate Buy" rating for the stock, with an average price target of $189.26.
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Rating of "Hold" by Brokerages
GE HealthCare Technologies Inc. (NASDAQ:GEHC) has received a consensus "Hold" rating from 17 brokerages, with an average 1-year price target of $80.66. The company's recent quarterly earnings showed mixed results, missing EPS estimates but exceeding revenue expectations with a 7.4% year-over-year increase. Insider buying, including purchases by the CEO, and significant institutional ownership highlight confidence in the stock despite analyst price target reductions.
Waystar Holding Corp. engages attendees at Florida HFMA Spring Conference with expert insights and giveaway
Waystar Holding Corp. is actively participating in the Florida HFMA Spring Conference, offering industry expertise and an interactive engagement at booth 14, including a Nike sneaker giveaway. The company aims to connect face-to-face with industry professionals and provide real-time answers to revenue cycle questions. Waystar has previously emphasized unified mid-cycle integration in healthcare and successfully helped OSF HealthCare improve query rates and financial performance.
Invesco S&P Spin-Off ETF (NY: CSD)
This article provides a stock quote and performance details for the Invesco S&P Spin-Off ETF (CSD). It outlines the ETF's current price, daily range, 52-week range, volume, dividend yield, and year-to-date performance. The article also includes a list of related news headlines, some of which reference spin-offs, mergers, and company performance.
Is Stryker (SYK) At An Attractive Price After Recent Share Price Swings
Stryker (SYK) has experienced recent share price volatility, with a 7.5% rise over the last week but declines over the past month, year-to-date, and year. Simply Wall St's valuation checks currently give Stryker a score of 2 out of 6. A Discounted Cash Flow (DCF) analysis suggests Stryker is undervalued by 16.5% at an estimated intrinsic value of $367.59 per share, while its P/E ratio of 35.24x makes it appear overvalued compared to the industry average and Simply Wall St's Fair Ratio of 31.22x.
Lantheus Holdings Inc stock (US5156731020): analysts see upside after recent volatility
Lantheus Holdings Inc (LNTH) shares have experienced volatility, yet Wall Street analysts maintain a positive outlook, projecting mid-single-digit upside over the next 12 months with a consensus price target around $99.71 USD. The company, a specialist in diagnostic imaging and theranostics, is driven by its PYLARIFY product for prostate cancer and strategic expansion into Alzheimer's diagnostics. Despite market risks like pricing pressure and competition, analysts rate the stock with a "moderate buy," recognizing its strong position in key healthcare trends.
AASTOCKS Financial News - GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC) reported first-quarter adjusted EPS of $0.99, which was below market expectations of $1.05, leading to a 14% stock drop. However, its quarterly sales reached $5.1 billion, surpassing expectations. The company reaffirmed its sales growth guidance of 3% to 4%.
A Look At GE HealthCare Technologies (GEHC) Valuation After Earnings Miss Guidance Cut And Legal Investigations
GE HealthCare Technologies (GEHC) is under scrutiny after missing Q1 earnings, cutting full-year EPS guidance, and facing legal investigations, resulting in a significant share price drop. Despite its valuation narrative suggesting it's 24% undervalued at $79.95 per share and ongoing product launches, the company faces headwinds from tariffs, regulatory uncertainty in China, and lower free cash flow, complicating its growth prospects. Investors are advised to consider both the potential opportunities in healthcare AI and the risks outlined in detailed analyses.
Invesco S&P Spin-Off ETF (NY: CSD)
This article provides detailed real-time stock information for the Invesco S&P Spin-Off ETF (CSD), including current trading data, historical performance metrics, and key financial figures. It also lists recent news headlines related to spin-offs, mergers, and companies within the ETF's holdings. The article concludes with frequently asked questions about CSD's public trading status and market details.
Rockford Register Star: Local News, Politics & Sports in Rockford, IL
This article from Rockford Register Star provides detailed financial information for the Invesco S&P Spin-Off ETF (NYSE: CSD), including its current price, trading volume, and performance metrics. It also features a collection of recent news headlines related to spin-offs, mergers, and companies associated with the ETF, such as Kyndryl, GE Vernova, and GXO Logistics. The content includes frequently asked questions about the ETF's public trading status and market capitalization.
Invesco S&P Spin-Off ETF (NY: CSD)
This article provides a detailed stock quote for the Invesco S&P Spin-Off ETF (CSD), including its current price, volume, trading ranges, and dividend yield. It also features a collection of recent news headlines related to spin-offs, mergers, and companies within the ETF's possible holdings, such as Kyndryl and GE Vernova, highlighting performance and strategic developments. The article concludes with frequently asked questions about the ETF's trading information.
Invesco S&P Spin-Off ETF (NY: CSD)
This article provides detailed stock information for the Invesco S&P Spin-Off ETF (CSD), including its current price, market performance, and related news headlines. It lists key financial metrics such as volume, open price, bid/ask, previous close, and dividend yield, along with year-to-date and historical performance data. The article also includes a collection of news articles related to spin-offs, mergers, and companies potentially impacting the ETF.
